Doctronic vs Cardinal Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Doctronic became the first AI to legally renew prescriptions in the US (190-med formulary, Utah); raised $40M Series B with 300K+ visitors as it expands state by state (March 2026).
About
Doctronic is a US-based AI telehealth company that has built a regulatory-compliant AI platform for medical consultations and prescription services. The company made history by becoming the first AI to legally renew prescriptions in the United States, initially operating in Utah under a pioneering regulatory framework that allows AI-assisted prescribing for a defined formulary of medications. Doctronic's platform enables patients to consult with an AI for common, well-understood health conditions and receive prescriptions for up to 190 medications without requiring a synchronous visit with a human physician.\n\nDoctronic's platform is designed to navigate the complex intersection of AI capability, medical regulation, and patient safety. Its AI conducts structured medical history intake, symptom assessment, and contraindication screening before generating prescription recommendations that are reviewed within a compliance framework. The platform targets patients seeking convenient, affordable access to prescription renewals and routine care for chronic and common conditions—a massive market given the primary care shortage in the United States. Doctronic operates at the forefront of AI in regulated healthcare, demonstrating that AI can deliver clinically appropriate care within legal guardrails.\n\nDoctronic raised a $40M Series B in 2026 to accelerate geographic expansion and broaden its formulary and condition coverage. With over 300,000 visitors to its platform, Doctronic has demonstrated real consumer demand for AI-mediated healthcare access. The company's Utah-first strategy allowed it to build a compliant, proven model before pursuing expansion to additional states with favorable telehealth regulations. As regulatory frameworks for AI in medicine evolve, Doctronic is positioned as a first-mover with a defensible regulatory and clinical knowledge base.
Dublin OH pharmaceutical distribution (NYSE: CAH) $230B+ revenue; specialty pharma GLP-1 distribution tailwind, at-Home Solutions growth, medical divestiture to Medline competing with McKesson and Cencora.
About
Cardinal Health, Inc. is a Dublin, Ohio-based healthcare distribution and medical products company — publicly traded on the New York Stock Exchange (NYSE: CAH) as an S&P 500 Health Care component — distributing pharmaceutical products to pharmacies, hospitals, and healthcare providers, and manufacturing and distributing medical and surgical supplies through approximately 44,000 employees. In fiscal year 2025 (ending June 2025), Cardinal Health generated revenues exceeding $230 billion in its Pharmaceutical and Specialty Solutions segment — reflecting the company's role as a pass-through distributor of branded and generic pharmaceuticals at near-zero margin on drug cost, where Cardinal Health earns distribution fees and rebate income on enormous volumes. CEO Jason Hollar has executed a two-segment strategy focused on optimizing pharmaceutical distribution (Pharmaceutical and Specialty Solutions — $227B+ revenue at low margin) and growing medical products profitability (Global Medical Products and Distribution — higher-margin branded surgical products, Cardinal Health brand commodities, and at-Home Solutions). The 2024 divestiture of the medical segment's Cardinal Health Brand product line to Medline Industries for $1.1 billion simplified the medical segment focus toward specialty distribution and home healthcare supply. Cardinal Health's specialty pharmaceutical distribution (oncology, rheumatology, rare disease biologics through Cardinal Health Specialty Solutions) is a growing higher-margin subsegment as pharmaceutical manufacturers contract with specialty distributors for controlled dispensing of limited-distribution drugs.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.